Log in
Enquire now
‌

US Patent 11697816 Artificial nucleic acid molecules

Patent 11697816 was granted and assigned to CureVac on July, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
CureVac
CureVac
0
Date Filed
June 28, 2016
0
Date of Patent
July 11, 2023
0
Patent Applicant
CureVac
CureVac
0
Patent Application Number
15195524
0
Patent Citations
‌
US Patent 8217016 Application of mRNA for use as a therapeutic agent for tumorous diseases
0
‌
US Patent 8383340 Method for purifying RNA on a preparative scale by means of HPLC
0
‌
US Patent 8968746 Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
0
‌
US Patent 9447431 Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
0
Patent Citations Received
‌
US Patent 11965000 Respiratory syncytial virus (RSV) vaccine
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11697816
0
Patent Primary Examiner
‌
Shin-Lin Chen
0
CPC Code
‌
C12N 15/86
0
‌
C12N 2830/50
0
‌
C12N 2510/00
0
‌
C12N 15/79
0
‌
C07H 21/04
0
‌
C12N 15/68
0
‌
C07H 21/02
0
‌
C12N 15/85
0

Find more entities like US Patent 11697816 Artificial nucleic acid molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us